Results 91 to 100 of about 2,405 (150)
Impact of Pre-Existing Cardiovascular and Metabolic Conditions on the Development of Heart Failure After Paclitaxel Therapy: Real-World Study Based on a Nationwide Claims Database in Japan. [PDF]
Iwane S +6 more
europepmc +1 more source
Potential Cost Savings in Medicare Part D for Otolaryngologic Medications. [PDF]
Tripathi OB +6 more
europepmc +1 more source
A Narrative Review on Nitrate-Rich Diets as Adjuncts to Antihypertensive Therapy: Enhancing Treatment Efficacy via Oxidative Stress Modulation. [PDF]
Silva-Cunha M +3 more
europepmc +1 more source
Diagnosis and treatment of early eosinophilic fasciitis: a case report. [PDF]
Ma J +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pharmacokinetics of Triamterene
Clinical and Experimental Hypertension, 1983The knowledge about the pharmacokinetics of triamterene (TA) was limited until recently. The metabolic pathway of TA is the formation of p-hydroxytriamterene (OH-TA), which is subsequently conjugated with active sulfate to form p-hydroxytriamterene sulfuric acid ester (OH-TA-ester). The phase-II-metabolite is surprisingly pharmacologically active.
H Knauf
exaly +3 more sources
Calcified Tissue International, 1987
A constant composition method has been used to compare the effects of triamterene renal stone material, synthetic triamterene precipitates, and soluble triamterene on the nucleation and crystallization kinetics of calcium oxalate in aqueous solution in vitro.
G H Nancollas, Nancollas George H
exaly +3 more sources
A constant composition method has been used to compare the effects of triamterene renal stone material, synthetic triamterene precipitates, and soluble triamterene on the nucleation and crystallization kinetics of calcium oxalate in aqueous solution in vitro.
G H Nancollas, Nancollas George H
exaly +3 more sources

